Share on StockTwits

Bodycote PLC (LON:BOY)‘s stock had its “outperform” rating reaffirmed by stock analysts at Credit Suisse in a report issued on Tuesday, ARN reports. They currently have a GBX 810 ($13.61) price target on the stock. Credit Suisse’s price objective indicates a potential upside of 10.05% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of Bodycote PLC in a research note on Tuesday. They now have a GBX 770 ($12.94) price target on the stock. Separately, analysts at Investec reiterated a “buy” rating on shares of Bodycote PLC in a research note on Tuesday. They now have a GBX 810 ($13.61) price target on the stock. Finally, analysts at FinnCap reiterated a “hold” rating on shares of Bodycote PLC in a research note on Tuesday. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of GBX 775.91 ($13.04).

Bodycote PLC (LON:BOY) traded down 1.80% on Tuesday, hitting GBX 736.00. 225,546 shares of the company’s stock traded hands. Bodycote PLC has a 52-week low of GBX 496.00 and a 52-week high of GBX 832.00. The stock’s 50-day moving average is GBX 783.5 and its 200-day moving average is GBX 696.2. The company’s market cap is £1.394 billion.

Bodycote plc (LON:BOY) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.